Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Unique molecular signatures as a hallmark of patients with metastatic breast cancer: Implications for current treatment paradigms

2 May 2014

Abstract excerpt

// Jennifer J. Wheler 1 , Barbara A. Parker 2 , Jack J. Lee 3 , Johnique T. Atkins 1 , Filip Janku 1 , Apostolia M. Tsimberidou 1 , Ralph Zinner 1 , Vivek Subbiah 1 , Siqing Fu 1 , Richard Schwab 2 , Stacy Moulder 4 , Vicente Valero 4 , Maria Schwaederle 5 , Roman Yelensky 6 , Vincent A. Miller 6 , M Philip J. Stephens 6 , Funda Meric-Bernstam 1 , Razelle Kurzrock 2 1 Department of Investigational Cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cancer-related Molecular Pathways
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24811890
DOI: 10.18632/oncotarget.1946

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Unique molecular signatures as a hallmark of patients with metastatic breast cancer: Implications for current treatment paradigmsPMID 24811890Read ↗

The Influence of Cancer Molecular Subtypes and Treatment on the Mutation Spectrum in Metastatic Breast Cancers.Semantic proximity Read ↗

The mutational landscape of a US Midwestern breast cancer cohort reveals subtype-specific cancer drivers and prognostic markers.Semantic proximity Read ↗

Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast Cancer.Semantic proximity Read ↗

Genetic alterations and their association with clinicopathologic characteristics in advanced breast carcinomas: focusing on clinically actionable genetic alterations.Semantic proximity Read ↗

Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment options.Semantic proximity Read ↗

Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific TreatmentsSemantic proximity Read ↗

Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigmsSemantic proximity Read ↗

A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practice.Semantic proximity Read ↗

Deciphering and Targeting Oncogenic Mutations and Pathways in Breast Cancer.Semantic proximity Read ↗

Targeted next-generation sequencing detects a high frequency of potentially actionable mutations in metastatic breast cancers.Semantic proximity Read ↗

Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic VulnerabilitiesSemantic proximity Read ↗

Molecular Pathology of Breast Tumors: Diagnostic and Actionable Genetic Alterations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.